scientific-writer 2.2.1__py3-none-any.whl → 2.2.3__py3-none-any.whl

scientific_writer/.claude/skills/treatment-plans/assets/quality_checklist.md

@@ -0,0 +1,471 @@
+# Treatment Plan Quality Assurance Checklist
+
+## Overview
+
+Use this checklist to ensure treatment plans meet professional standards for completeness, quality, safety, and regulatory compliance. Review each section before finalizing the plan.
+
+---
+
+## Section 1: Completeness - Required Components
+
+### ☐ Patient Information
+- [ ] Patient identifier (de-identified if sharing)
+- [ ] Age range (not exact date of birth)
+- [ ] Sex and relevant demographics
+- [ ] Date of plan creation
+- [ ] Provider name and credentials
+- [ ] Facility/practice name
+- [ ] HIPAA de-identification notice included
+
+### ☐ Diagnosis and Assessment
+- [ ] Primary diagnosis clearly stated
+- [ ] ICD-10 code(s) included
+- [ ] Secondary diagnoses and comorbidities listed
+- [ ] Disease severity/staging documented
+- [ ] Baseline functional status assessed
+- [ ] Risk stratification performed (if applicable)
+
+### ☐ Treatment Goals
+- [ ] Short-term goals present (1-3 months)
+- [ ] Long-term goals present (6-12 months)
+- [ ] Goals meet SMART criteria (see Section 2)
+- [ ] Patient-centered goals included
+- [ ] Goals are prioritized or organized
+
+### ☐ Interventions
+- [ ] Pharmacological interventions specified
+- [ ] Non-pharmacological interventions included
+- [ ] Procedural interventions or referrals noted
+- [ ] Each intervention has clear rationale
+- [ ] Evidence-based or guideline-concordant
+
+### ☐ Timeline and Schedule
+- [ ] Treatment phases with durations defined
+- [ ] Appointment frequency specified
+- [ ] Milestone assessments scheduled
+- [ ] Expected total treatment duration stated
+
+### ☐ Monitoring Parameters
+- [ ] Clinical outcomes to track identified
+- [ ] Baseline values documented
+- [ ] Target values specified
+- [ ] Monitoring frequency defined
+- [ ] Assessment tools/scales named
+
+### ☐ Expected Outcomes
+- [ ] Primary outcome measures stated
+- [ ] Success criteria defined
+- [ ] Timeline for improvement indicated
+- [ ] Criteria for treatment modification noted
+
+### ☐ Follow-up Plan
+- [ ] Next appointment scheduled
+- [ ] Follow-up frequency specified
+- [ ] Communication plan outlined
+- [ ] Emergency contact procedures included
+
+### ☐ Patient Education
+- [ ] Condition education documented
+- [ ] Self-management skills training noted
+- [ ] Warning signs communicated
+- [ ] Resources and support listed
+
+### ☐ Risk Mitigation and Safety
+- [ ] Potential adverse effects identified
+- [ ] Safety monitoring plan included
+- [ ] Emergency procedures outlined
+- [ ] Complication prevention addressed
+
+### ☐ Signature and Date
+- [ ] Provider signature line
+- [ ] Provider name and credentials
+- [ ] Date of plan
+- [ ] Patient acknowledgment (if applicable)
+
+---
+
+## Section 2: SMART Goals Quality
+
+For each treatment goal, verify it meets SMART criteria:
+
+### ☐ Specific
+- [ ] Goal clearly defines what will be accomplished
+- [ ] No vague language (e.g., "improve", "better")
+- [ ] Specific outcome stated
+
+**Example**: "Reduce HbA1c from 8.5% to <7%" ✓  
+**Not**: "Improve diabetes control" ✗
+
+### ☐ Measurable
+- [ ] Quantifiable metric or observable criterion included
+- [ ] Baseline value documented
+- [ ] Target value specified
+
+**Example**: "Walk 300 feet with walker independently" ✓  
+**Not**: "Walk further" ✗
+
+### ☐ Achievable
+- [ ] Realistic given patient's condition and capabilities
+- [ ] Resources available to support goal
+- [ ] Timeframe is reasonable
+- [ ] Treatment efficacy supports goal
+
+**Example**: "Reduce pain from 7/10 to 4/10 in 6 weeks" ✓  
+**Not**: "Eliminate all pain in 1 week" ✗
+
+### ☐ Relevant
+- [ ] Aligned with patient values and priorities
+- [ ] Clinically meaningful
+- [ ] Addresses patient's functional limitations
+- [ ] Integrated with overall treatment objectives
+
+**Example**: "Return to work with modifications within 3 months" ✓  
+**Not**: "Lab value improvement" (if patient doesn't care about it) ✗
+
+### ☐ Time-bound
+- [ ] Specific deadline or timeframe stated
+- [ ] Reassessment interval defined
+- [ ] Action frequency specified (if applicable)
+
+**Example**: "Within 8 weeks" or "By month 3" ✓  
+**Not**: "Eventually" or "Soon" ✗
+
+---
+
+## Section 3: Clinical Quality
+
+### ☐ Evidence-Based Practice
+- [ ] Interventions based on current evidence
+- [ ] Clinical practice guidelines followed
+- [ ] Guideline deviations explained and justified
+- [ ] Literature or evidence cited (if formal plan)
+
+### ☐ Medication Documentation (if applicable)
+- [ ] Generic drug names used
+- [ ] Specific dose, route, frequency documented
+- [ ] Indication/rationale provided for each medication
+- [ ] Adverse effects to monitor noted
+- [ ] Drug interactions considered
+- [ ] Titration plan included if applicable
+
+### ☐ Assessment Tools
+- [ ] Validated assessment tools used when available
+- [ ] Tools appropriate for condition (PHQ-9, FIM, Berg, etc.)
+- [ ] Baseline scores documented
+- [ ] Target scores specified
+- [ ] Reassessment schedule defined
+
+### ☐ Multidisciplinary Coordination (if applicable)
+- [ ] Roles of team members defined
+- [ ] Communication plan among providers specified
+- [ ] Care transitions addressed
+- [ ] Specialist recommendations integrated
+
+### ☐ Preventive Care Integration
+- [ ] Age-appropriate screening included
+- [ ] Vaccination schedule noted
+- [ ] Lifestyle counseling documented
+- [ ] Health maintenance addressed
+
+---
+
+## Section 4: Patient-Centered Care
+
+### ☐ Shared Decision-Making
+- [ ] Patient preferences documented
+- [ ] Treatment options discussed
+- [ ] Risks and benefits explained
+- [ ] Patient values incorporated into goals
+- [ ] Alternative treatments considered
+
+### ☐ Health Literacy
+- [ ] Language appropriate for patient understanding
+- [ ] Medical jargon explained or avoided
+- [ ] Teach-back method used or planned
+- [ ] Written materials at appropriate reading level
+
+### ☐ Cultural Competence
+- [ ] Cultural beliefs and practices considered
+- [ ] Language barriers addressed (interpreter if needed)
+- [ ] Cultural adaptations made when appropriate
+- [ ] Religious/spiritual preferences respected
+
+### ☐ Social Determinants of Health
+- [ ] Social needs screened (food, housing, transportation)
+- [ ] Barriers to care identified
+- [ ] Community resources provided
+- [ ] Financial concerns addressed (medication costs, etc.)
+
+### ☐ Patient Engagement
+- [ ] Patient actively involved in goal-setting
+- [ ] Self-management support provided
+- [ ] Patient education tailored to individual
+- [ ] Follow-up preferences considered
+
+---
+
+## Section 5: Safety and Risk Management
+
+### ☐ Medication Safety
+- [ ] Allergy history documented
+- [ ] Polypharmacy reviewed (deprescribing considered)
+- [ ] High-risk medications monitored appropriately
+- [ ] Drug-drug interactions checked
+- [ ] Renal/hepatic dosing adjustments made if needed
+
+### ☐ Fall Prevention (if relevant)
+- [ ] Fall risk assessed
+- [ ] Fall prevention strategies included
+- [ ] Environmental modifications recommended
+- [ ] Assistive devices prescribed
+
+### ☐ Infection Prevention (if relevant)
+- [ ] Immunizations up to date
+- [ ] Prophylactic antibiotics if indicated
+- [ ] Infection signs and symptoms patient education
+
+### ☐ Emergency Preparedness
+- [ ] Emergency warning signs clearly listed
+- [ ] When to call 911 specified
+- [ ] When to call provider defined
+- [ ] Emergency contact numbers provided
+
+### ☐ Suicide/Violence Risk (mental health plans)
+- [ ] Risk assessment documented
+- [ ] Safety plan created if ideation present
+- [ ] Means restriction addressed
+- [ ] Crisis resources provided (988 lifeline)
+- [ ] Follow-up frequency appropriate for risk level
+
+### ☐ Opioid Safety (pain management plans)
+- [ ] Opioid risk assessment completed (ORT, SOAPP)
+- [ ] Informed consent discussion documented
+- [ ] Treatment agreement signed
+- [ ] PDMP checked
+- [ ] Naloxone co-prescribed
+- [ ] UDS plan included
+
+---
+
+## Section 6: Regulatory Compliance
+
+### ☐ HIPAA Compliance
+- [ ] Protected health information (PHI) safeguarded
+- [ ] De-identification per Safe Harbor method (if sharing)
+- [ ] All 18 HIPAA identifiers removed (if de-identified)
+- [ ] Minimum necessary principle followed
+
+### ☐ Informed Consent
+- [ ] Consent discussion documented
+- [ ] Patient understanding verified
+- [ ] Risks and benefits explained
+- [ ] Alternative treatments discussed
+- [ ] Patient agreement documented
+
+### ☐ Medical Necessity
+- [ ] Treatment medically necessary for diagnosis
+- [ ] Interventions appropriate for severity
+- [ ] Evidence supports treatment choices
+- [ ] Frequency and duration justified
+
+### ☐ Billing and Coding
+- [ ] ICD-10 diagnosis codes included
+- [ ] CPT procedure codes (if procedures planned)
+- [ ] Documentation supports billing level
+- [ ] Medical necessity for services demonstrated
+
+### ☐ Quality Measure Support
+- [ ] Elements support quality reporting (HEDIS, MIPS)
+- [ ] Chronic disease management protocols followed
+- [ ] Preventive care documented
+- [ ] Patient safety indicators addressed
+
+### ☐ Specialty-Specific Regulations
+- [ ] 42 CFR Part 2 compliance (if substance use disorder treatment)
+- [ ] CDC opioid guidelines followed (if opioid prescription)
+- [ ] Joint Commission standards met (if applicable)
+- [ ] State-specific requirements addressed
+
+---
+
+## Section 7: Documentation Standards
+
+### ☐ Clarity and Precision
+- [ ] Professional medical terminology used appropriately
+- [ ] Abbreviations defined on first use
+- [ ] No ambiguous language
+- [ ] Specific rather than vague descriptions
+
+### ☐ Accuracy
+- [ ] Factually correct information
+- [ ] Current evidence-based recommendations
+- [ ] Correct medication dosing and frequencies
+- [ ] Proper ICD-10 and CPT coding
+
+### ☐ Organization
+- [ ] Logical flow and structure
+- [ ] Consistent formatting
+- [ ] Easy to locate key information
+- [ ] Headings and sections clearly labeled
+
+### ☐ Legibility (if handwritten or hybrid)
+- [ ] Handwriting legible
+- [ ] No unclear abbreviations
+- [ ] Typed portions clear
+- [ ] Signatures legible with printed name
+
+### ☐ Authentication
+- [ ] Provider name clearly stated
+- [ ] Credentials included
+- [ ] Date of plan present
+- [ ] Signature obtained (electronic or handwritten)
+
+---
+
+## Section 8: Special Considerations by Plan Type
+
+### For General Medical Plans:
+- [ ] Chronic disease management protocols followed
+- [ ] Guideline-based targets used (HbA1c, BP, lipids)
+- [ ] Medication regimen optimized
+- [ ] Comorbidities addressed
+- [ ] Preventive care integrated
+
+### For Rehabilitation Plans:
+- [ ] Functional assessments with validated tools (FIM, Berg)
+- [ ] Impairment, activity, and participation goals included
+- [ ] Therapy frequency and duration specified
+- [ ] Home exercise program documented
+- [ ] DME and environmental modifications listed
+- [ ] Discharge criteria defined
+
+### For Mental Health Plans:
+- [ ] DSM-5 diagnostic criteria met
+- [ ] Symptom severity assessed (PHQ-9, GAD-7, etc.)
+- [ ] Suicide/violence risk assessed
+- [ ] Safety plan created (if indicated)
+- [ ] Evidence-based psychotherapy specified
+- [ ] Medication trials and responses documented
+- [ ] Functional and recovery-oriented goals included
+
+### For Chronic Disease Management Plans:
+- [ ] All active conditions prioritized
+- [ ] Medication synergies identified
+- [ ] Polypharmacy addressed
+- [ ] Care coordination plan clear
+- [ ] Registry/population health integration noted
+- [ ] Transition management included
+
+### For Perioperative Plans:
+- [ ] Preoperative risk assessment (RCRI, ASA, Caprini)
+- [ ] Medical optimization documented
+- [ ] ERAS elements included (if applicable)
+- [ ] Postoperative milestones defined
+- [ ] Discharge criteria specified
+- [ ] VTE prophylaxis plan included
+
+### For Pain Management Plans:
+- [ ] Comprehensive pain assessment (location, quality, intensity, impact)
+- [ ] Pain type classified (nociceptive, neuropathic, nociplastic)
+- [ ] Multimodal analgesia approach
+- [ ] Opioid risk assessment (if opioids considered)
+- [ ] Functional goals emphasized (not just pain scores)
+- [ ] Psychological screening and intervention included
+- [ ] CDC opioid guidelines followed (if prescribing)
+
+---
+
+## Section 9: Final Review
+
+### ☐ Proofreading
+- [ ] Spelling and grammar checked
+- [ ] No typos or errors
+- [ ] Consistent terminology throughout
+- [ ] Patient name correct throughout (if not de-identified)
+
+### ☐ Completeness Verification
+- [ ] All placeholder text replaced with patient-specific information
+- [ ] All bracketed [fields] customized
+- [ ] No "TBD" or "to be completed" items remaining
+- [ ] All required sections complete
+
+### ☐ Quality Assurance
+- [ ] Plan reviewed by provider
+- [ ] Peer review completed (if applicable)
+- [ ] Compliance verification done
+- [ ] Automated checks run (if available scripts used)
+
+### ☐ Patient Review Preparation
+- [ ] Patient-friendly summary prepared (if needed)
+- [ ] Patient education materials gathered
+- [ ] Consent forms ready for signature
+- [ ] Questions anticipated and prepared to address
+
+---
+
+## Scoring and Interpretation
+
+**Total Items**: ~150 (varies by plan type)
+
+### Scoring:
+- Count number of checked items
+- Calculate percentage: (Checked / Total) × 100
+
+### Interpretation:
+- **95-100%**: Excellent - Plan meets highest quality standards
+- **85-94%**: Good - Plan is high quality with minor gaps
+- **70-84%**: Acceptable - Plan is adequate but has areas needing improvement
+- **<70%**: Needs Improvement - Significant gaps in quality or compliance
+
+### Critical Items (Must Have):
+The following items are critical and must be present:
+- ✓ Patient identifier and de-identification notice
+- ✓ Primary diagnosis with ICD-10 code
+- ✓ At least 3 SMART goals
+- ✓ Interventions with rationales
+- ✓ Monitoring plan
+- ✓ Follow-up plan
+- ✓ Patient education
+- ✓ Safety/risk mitigation
+- ✓ Emergency procedures
+- ✓ Provider signature
+
+If any critical item is missing, plan should not be finalized until corrected.
+
+---
+
+## Usage Instructions
+
+1. **Review each section** systematically
+2. **Check boxes** as criteria are met
+3. **Note deficiencies** for correction
+4. **Calculate score** to assess overall quality
+5. **Address gaps** before finalizing
+6. **Document review** with reviewer name and date
+
+**Reviewer**: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
+
+**Date Reviewed**: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
+
+**Score**: \_\_\_\_\_% (\_\_\_\_ items checked / \_\_\_\_ total items)
+
+**Status**:
+- [ ] Approved for use
+- [ ] Approved with minor revisions
+- [ ] Requires significant revision
+- [ ] Not approved
+
+**Comments/Recommendations**:
+
+\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
+
+\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
+
+\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
+
+---
+
+**Document Version**: 1.0  
+**Last Updated**: January 2025  
+**Next Review**: Annually or with guideline updates
+